Lip cancer: Reconsidering the at-risk patients with pathological assessment.
Ant A, Kilic C, Baltu Y, Duran AB, Tunccan T, Ozlugedik S, Bozdogan N.
Oral Dis. 2019 Apr;25(3):742-749. doi: 10.1111/odi.13017. Epub 2019 Jan 23.
PMID:30548899
Occupational variation in the incidence of lip cancer in the Nordic countries.
Mroueh R, Carpén T, Mäkitie A, Hansen J, Heikkinen S, Lynge E, Martinsen JI, Selander J, Mehlum IS, Torfadottir JE, Salo T, Pukkala E.
Acta Oncol. 2023 Jun;62(6):541-549. doi: 10.1080/0284186X.2023.2224053. Epub 2023 Jun 19.
PMID:37337140
Lip Cancer: 20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period and Disease Duration A Systematic Review of 19,213 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.5).
Milano AF.
J Insur Med. 2023 Mar 7;49(4):1-12. doi: 10.17849/insm-49-4-1-12.1.
PMID:36883809
The relevance of miRNAs as promising biomarkers in lip cancer.
Assao A, Domingues MAC, Minicucci EM, Marchi FA, Coutinho-Camillo CM, Oliveira DT.